Literature DB >> 10606739

Histone- and chromatin-binding activity of template activating factor-I.

K Matsumoto1, K Nagata, M Okuwaki, M Tsujimoto.   

Abstract

Template activating factor-I (TAF-I) is a histone-binding chromatin remodeling factor. We recently found that TAF-I is capable of mediating decondensation of Xenopus sperm chromatin by releasing sperm-specific basic proteins. Here we present evidence that TAF-I preferentially binds to histone H3 among four core histones. Immunofluorescent staining revealed that TAF-I binds to the decondensed sperm chromatin, of which protein components predominantly consist of histones H3 and H4.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10606739     DOI： 10.1016/s0014-5793(99)01632-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


  12 in total

1.  SET nuclear oncogene associates with microcephalin/MCPH1 and regulates chromosome condensation.

Authors:  Justin W Leung; Andrea Leitch; Jamie L Wood; Charles Shaw-Smith; Kay Metcalfe; Louise S Bicknell; Andrew P Jackson; Junjie Chen
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain.

Authors:  Saku Miyamoto; Toru Suzuki; Shinsuke Muto; Kenichi Aizawa; Akatsuki Kimura; Yoshiko Mizuno; Tomoko Nagino; Yasushi Imai; Naruhiko Adachi; Masami Horikoshi; Ryozo Nagai
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates.

Authors:  Matthew J Gamble; Hediye Erdjument-Bromage; Paul Tempst; Leonard P Freedman; Robert P Fisher
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  Involvement of template-activating factor I/SET in transcription of adenovirus early genes as a positive-acting factor.

Authors:  Hirohito Haruki; Mitsuru Okuwaki; Makoto Miyagishi; Kazunari Taira; Kyosuke Nagata
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity.

Authors:  Shinsuke Muto; Miki Senda; Yusuke Akai; Lui Sato; Toru Suzuki; Ryozo Nagai; Toshiya Senda; Masami Horikoshi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

6.  HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A.

Authors:  Zusen Fan; Paul J Beresford; Dong Zhang; Judy Lieberman
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

7.  Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity.

Authors:  Kensaku Murano; Mitsuru Okuwaki; Miharu Hisaoka; Kyosuke Nagata
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

8.  SET oncoprotein accumulation regulates transcription through DNA demethylation and histone hypoacetylation.

Authors:  Luciana O Almeida; Marinaldo P C Neto; Lucas O Sousa; Maryna A Tannous; Carlos Curti; Andreia M Leopoldino
Journal:  Oncotarget       Date:  2017-04-18

9.  Identification of distinct SET/TAF-Ibeta domains required for core histone binding and quantitative characterisation of the interaction.

Authors:  Zoe Karetsou; Anastasia Emmanouilidou; Ioannis Sanidas; Stamatis Liokatis; Eleni Nikolakaki; Anastasia S Politou; Thomais Papamarcaki
Journal:  BMC Biochem       Date:  2009-04-09       Impact factor: 4.059

10.  Alternative SET/TAFI Promoters Regulate Embryonic Stem Cell Differentiation.

Authors:  Raghu Ram Edupuganti; Arigela Harikumar; Yair Aaronson; Alva Biran; Badi Sri Sailaja; Malka Nissim-Rafinia; Gajendra Kumar Azad; Malkiel A Cohen; Jung Eun Park; Chikdu S Shivalila; Styliani Markoulaki; Siu Kwan Sze; Rudolf Jaenisch; Eran Meshorer
Journal:  Stem Cell Reports       Date:  2017-09-28       Impact factor: 7.765
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.